The Indian stock market enters a crucial week with multiple catalysts that could shape investor sentiment. From RBI’s monetary policy decision to quarterly earnings announcements and ongoing tariff concerns, here’s your comprehensive guide to navigating the markets ahead.
RBI Monetary Policy Decision: The Week’s Main Event
Date & Time: Wednesday, August 6th, 2025 at 10:00 AM IST
The Reserve Bank of India’s Monetary Policy Committee (MPC) outcome takes center stage this week, especially with mounting uncertainty around Trump administration’s tariff policies. While the central bank is widely expected to maintain repo rates unchanged, all eyes will be on Governor Sanjay Malhotra’s post-decision commentary.
The market will closely scrutinize the RBI’s stance on:
- Impact of global tariff tensions on domestic inflation
- Foreign exchange stability measures
- Economic growth outlook amid external headwinds
Q1 FY26 Earnings Calendar: Key Companies to Watch
The first quarter earnings season reaches its conclusion with several marquee companies scheduled to report results:
Monday, August 4th
- AUROPHARMA – Key pharma player facing tariff headwinds
- DLF – Real estate sector update
- ESCORTS – Auto ancillary performance
- SHREECEM – Cement sector insights
Tuesday, August 5th
- ADANIPORTS – Infrastructure play
- BRITANNIA – FMCG sector strength
- LUPIN – Pharmaceutical sector developments
- BERGEPAINT – Paint industry dynamics
Wednesday, August 6th
- BAJAJ AUTO – Two-wheeler market leader
- DIVISLABS – Specialty pharma focus
- TRENT – Retail sector performance
- PIDILITE – Specialty chemicals
Thursday, August 7th
- TITAN – Jewelry and watches segment
- BIOCON – Biotechnology developments
- HINDPETRO – Oil refining sector
- APOLLOTYRE – Auto components
Friday, August 8th
- TATAMOTORS – Auto sector bellwether
- SBIN – Banking sector health
- GRASIM – Diversified conglomerate
- NAUKRI – Digital services sector
JSW Cement IPO: Major Public Issue This Week
Issue Size: ₹3,600 crores Structure: Fresh issue of ₹1,600 crores + OFS of ₹2,000 crores Subscription Period: August 7-11, 2025 Allotment Date: August 12, 2025 Listing Date: August 14, 2025 (BSE & NSE)
Technical Analysis: Nifty 50 at Critical Juncture
Current Market Levels
- Nifty CMP: 24,565
- Bank Nifty CMP: 50,618
Key Technical Observations
The Nifty has formed bearish candles on both weekly and monthly charts, indicating strong resistance around the psychological 25,000 mark. The index faces a critical test with major resistance at 25,600.
Support Levels:
- Immediate Support: 24,473 (June 13th low)
- Major Support: 23,936 (May 9th low)
- 200 DMA: 24,050
Resistance Levels:
- Immediate Resistance: 25,000
- Major Resistance: 25,421/25,600
Options Data Insights
- Trading Range: 23,500-25,300
- Maximum Call OI: 26,000 strike
- Maximum Put OI: 25,000 strike
- Nifty PCR: 1.03 (Negative bias)
- Bank Nifty PCR: 0.86 (Negative bias)
Sector Outlook: Winners and Laggards
Bullish Sector
FMCG: The fast-moving consumer goods sector shows resilience amid market volatility, supported by stable demand and pricing power.
Bearish Sectors
- IT: Technology stocks face headwinds from global uncertainty
- PHARMA: Under pressure from potential US tariff implications
- ENERGY: Commodity price volatility concerns
- MEDIA & REALTY: Cyclical weakness continues
Stock Recommendations
Bullish Picks
- HUL: FMCG leader with strong fundamentals
- EICHERMOT: Premium motorcycle segment strength
- KAYNES: Technology solutions provider
Bearish Outlook
Key stocks facing headwinds include INFY, UPL, DLF, PFC, DRREDDY, SUNPHARMA, and ADANI group companies.
Featured Trade Idea: Aurobindo Pharma
Recommendation: SELL Current Price: ₹1,080 Targets: ₹1,021 / ₹975 / ₹901 Stop Loss: ₹1,173 Holding Period: 1-3 months
Investment Rationale
Aurobindo Pharma, despite being a market leader in US generics with $3.5 billion FY24 turnover, faces significant headwinds from potential US tariffs on Indian pharmaceutical imports. The stock has shown technical breakdown patterns since September 2024.
Key Fundamentals:
- Market Cap: ₹63,206 crores
- P/E Ratio: 18.1
- 52-Week Range: ₹994-₹1,593
- Q4 Revenue: ₹8,382 crores (highest quarterly)
Market Strategy: Cautious Approach Recommended
Given the current market dynamics, investors should adopt a defensive stance. The combination of:
- Overbought market conditions
- Tariff uncertainty
- Technical resistance at key levels
Suggests that caution should remain the primary investment theme. The market’s bullish stance will only be confirmed above the 25,000 mark on a sustained basis.
Key Levels to Watch
For Nifty:
- Bulls need to reclaim 25,000 decisively
- Bears target 24,200 and then 23,936
- 200 DMA at 24,050 remains crucial support
For Bank Nifty:
- Resistance at 56,700/58,000
- Support at 54,200/52,900
- 200 DMA at 52,589
Conclusion
This week presents a confluence of events that could determine near-term market direction. While RBI’s policy stance and earnings results will provide fundamental cues, the ongoing tariff situation adds an element of uncertainty. Investors should remain selective and maintain proper risk management protocols.
The market’s technical setup suggests limited upside until key resistance levels are broken, making this an ideal time for tactical trading rather than aggressive positioning.
Disclaimer: This analysis is for educational purposes only. Stock market investments are subject to market risks. Please consult your financial advisor before making investment decisions. Past performance does not guarantee future results.